Oruka Therapeutics Inc
NASDAQ: ORKA1 known investors
Find your way into Oruka Therapeutics Inc
Oruka is a biopharmaceutical company developing monoclonal antibody therapies aimed at treating plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory conditions with fewer annual doses. Its pipeline includes clinical-stage candidates ORKA-001 and ORKA-002 for moderate-to-severe plaque psoriasis.
Founders & leadership
LK
Lawrence KleininChief Executive Officer and Director
Investors · 1
In the news
Frequently asked questions
- What does Oruka Therapeutics Inc do?
- Oruka is a biopharmaceutical company developing monoclonal antibody therapies aimed at treating plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory conditions with fewer annual doses. Its pipeline includes clinical-stage candidates ORKA-001 and ORKA-002 for moderate-to-severe plaque psoriasis.
- Who are Oruka Therapeutics Inc's investors?
- Oruka Therapeutics Inc's investors include SR One Capital Management.